摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-2-甲基丙烷盐酸盐 | 10017-37-5

中文名称
2-氨基-2-甲基丙烷盐酸盐
中文别名
叔丁胺盐酸盐
英文名称
tert-butylamine hydrochloride
英文别名
tert-butylammonium chloride;2-methylpropan-2-amine hydrochloride;t-butylammonium chloride;2-methyl-2-propylamine hydrochloride;TBAC;hydron;2-methylpropan-2-amine;chloride
2-氨基-2-甲基丙烷盐酸盐化学式
CAS
10017-37-5
化学式
C4H12N*Cl
mdl
MFCD00042027
分子量
109.599
InChiKey
DLDIDQIZPBIVNQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    291 °C (decomp)

计算性质

  • 辛醇/水分配系数(LogP):
    0.43
  • 重原子数:
    6
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    26
  • 氢给体数:
    2
  • 氢受体数:
    1

安全信息

  • 危险品标志:
    Xn
  • 危险类别码:
    R22
  • 储存条件:
    室温下,在氮气环境中

SDS

SDS:c6e1f7242597ff487235f5158fabb60f
查看

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : tert-Butylamine hydrochloride
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 10017-37-5
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
Precautionary statement(s) none
Supplemental Hazard none
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Synonyms : 2-Amino-2-methylpropane
Formula : C4H11N · HCl
Molecular Weight : 109,60 g/mol
CAS-No. : 10017-37-5
EC-No. : 233-009-5
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
tert-Butylamine hydrochloride
CAS-No. 10017-37-5 Acute Tox. 4; H302 <= 100 %
EC-No. 233-009-5
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
tert-Butylamine hydrochloride
CAS-No. 10017-37-5 Xn, R22 <= 100 %
EC-No. 233-009-5
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Hydrogen chloride gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Air sensitive. Sensitive to carbon dioxide Store under inert gas. Moisture sensitive.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: powder
Colour: white
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
LD50 Oral - mouse - 1.750 mg/kg
Remarks: Drowsiness
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: EO5201000

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Thermolysis of cis and trans azoalkanes
    摘要:
    DOI:
    10.1021/ja00856a026
  • 作为产物:
    描述:
    叔丁胺盐酸 作用下, 以 乙醇 为溶剂, 生成 2-氨基-2-甲基丙烷盐酸盐
    参考文献:
    名称:
    Preventing thermolysis: precursor design for volatile copper compounds
    摘要:
    合成了一种铜(I)亚氨基吡咯烷酸盐,并通过热重分析(TGA)、溶液基1H NMR研究和表面化学评估其热稳定性和分解机制。铜(I)叔丁基亚氨基-2,2-二甲基吡咯烷酸盐(1)表现出优越的热稳定性,在TGA实验中在300 °C以下几乎没有分解,并且在165 °C的溶液中经过3周也没有分解。
    DOI:
    10.1039/c2cc35415b
  • 作为试剂:
    描述:
    硫酸二甲酯三氟乙酸sodium hydroxide2-氨基-2-甲基丙烷盐酸盐 作用下, 以 二氯甲烷 为溶剂, 反应 6.0h, 以76%的产率得到tert-butyl 4-(4-(methylamino)-3-nitrophenoxy)picolinate
    参考文献:
    名称:
    WO2008/11154
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Cyclic (Alkyl)(amino)carbene Ligand-Promoted Nitro Deoxygenative Hydroboration with Chromium Catalysis: Scope, Mechanism, and Applications
    作者:Lixing Zhao、Chenyang Hu、Xuefeng Cong、Gongda Deng、Liu Leo Liu、Meiming Luo、Xiaoming Zeng
    DOI:10.1021/jacs.0c12318
    日期:2021.1.27
    Transition metal catalysis that utilizes N-heterocyclic carbenes as noninnocent ligands in promoting transformations has not been well studied. We report here a cyclic (alkyl)(amino)carbene (CAAC) ligand-promoted nitro deoxygenative hydroboration with cost-effective chromium catalysis. Using 1 mol % of CAAC-Cr precatalyst, the addition of HBpin to nitro scaffolds leads to deoxygenation, allowing for
    利用 N-杂环卡宾作为非无害配体促进转化的过渡金属催化尚未得到很好的研究。我们在这里报告了具有成本效益的铬催化的环状(烷基)(氨基)卡宾(CAAC)配体促进的硝基脱氧硼氢化反应。使用 1 mol % 的 CAAC-Cr 预催化剂,将 HBpin 添加到硝基支架上会导致脱氧,从而保留各种可还原的官能团和敏感基团对硼氢化的相容性,从而提供一种温和、化学选择性和易于形成的策略苯胺,以及杂芳基和脂肪胺衍生物,具有广泛的范围和特别高的转换数(高达 1.8 × 106)。基于理论计算的机械研究,表明CAAC配体在促进HBpin氢化物极性反转中起重要作用;它用作 H 穿梭以促进脱氧硼氢化。通过这种策略制备的几种市售药物突出了其在药物化学中的潜在应用。
  • A Physical Organic Approach to Tuning Reagents for Selective and Stable Methionine Bioconjugation
    作者:Alec H. Christian、Shang Jia、Wendy Cao、Patricia Zhang、Arismel Tena Meza、Matthew S. Sigman、Christopher J. Chang、F. Dean Toste
    DOI:10.1021/jacs.9b04744
    日期:2019.8.14
    We report a data-driven, physical organic approach to the development of new methionine-selective bioconjugation reagents with tunable adduct stabilities. Statistical modeling of structural features described by intrinsic physical organic parameters was applied to the development of a predictive model and to gain insight into features driving the stability of adducts formed from the chemoselective
    我们报告了一种数据驱动的物理有机方法来开发具有可调加合物稳定性的新型蛋氨酸选择性生物共轭试剂。将由内在物理有机参数描述的结构特征的统计模型应用于预测模型的开发,并深入了解通过氧化还原激活化学标记 (ReACT) 氧化氮丙啶和甲硫氨酸硫醚伙伴化学选择性偶联形成的加合物稳定性的驱动特征。从这些分析中,揭示了硫酰亚胺稳定性和硫酰亚胺ν (C=O)伸缩频率之间的相关性。我们利用该分析所揭示的加合物稳定性的合理收益来实现用于肽装订的双氧氮杂环丙烷试剂的设计和合成。事实上,我们观察到,与未装订的同源物相比,通过 ReACT 装订甲硫氨酸形成的大环肽表现出对活细胞的吸收有所改善,这凸显了这种独特的化学工具用于硫醚修饰的潜在效用。这项工作为更广泛地使用数据驱动方法进行生物共轭化学和其他化学生物学应用提供了一个模板。
  • Thermal properties of H2SnCl6 complexes
    作者:Tadeusz Janiak、Jerzy Błażejowski
    DOI:10.1016/0040-6031(89)87045-5
    日期:1989.3
    Russell-Jones theory for the dissociative volatilization process and a standard approach based on the Arrhenius model. The values of the parameters characterizing the thermal properties of alkanaminium hexachlorostannates, i.e. temperatures of the thermal effects, and the thermochemical and kinetic constants of thermolysis, depend on the number, length and structure of the alkyl substituent. The essential
    摘要 热分析方法(DTA、TG 和 DTG)用于研究具有通式 [(CnH2n+1)pNH4-p]2SnCl6(其中 n = 1–4 和 p = 2–4)的无支链复合盐的热行为和其他几种环状和开链支链脂肪族链烷胺六氯锡酸盐。这些化合物的热解离通常可以使用等式来概括,其中 A 表示烷基(a = 0 和 s = 1 表示季铵盐,a = 1 和 s = 0 表示其他研究的化合物)。具有简单结构的衍生物的热解发生在一个步骤中并导致它们的完全挥发。其他化合物的分解,通常具有复杂的结构,伴随着副反应。实验 TG 曲线用于检查热解的热力学和动力学。热解离焓基于范特霍夫方程进行评估。导出的值与可用的文献数据一起用于确定盐的形成焓和晶格能。后者的数量也使用 Kapustinskii-Yatsimirskii 公式进行了检查。使用Jacobs 和Russell-Jones 解离挥发过程理论和基于Arrhenius
  • Synthesis, spectral characterization and crystal structures of organophosphonic diamides: pyramidal nitrogen centers and hydrogen bonding in [PhP(O)(NH<sup>t</sup>Bu)<sub>2</sub>], [PhP(O)(NHDipp)<sub>2</sub>] (Dipp = 2,6-<sup>i</sup>Pr<sub>2</sub>C<sub>6</sub>H<sub>3</sub>) and [<sup>t</sup>BuP(O)(NH<sup>i</sup>Pr)<sub>2</sub>]
    作者:Ramaswamy Murugavel、Ramasamy Pothiraja
    DOI:10.1039/b300035d
    日期:——
    characterized by elemental analysis and by IR, EI mass and NMR (1H and 31P) spectroscopy. The molecular structures of [PhP(O)(NHtBu)2] (1), [PhPO(NHDipp)2] (2) and [tBuP(O)(NHiPr)2] (7) have been determined by single crystal X-ray diffraction studies. The amido nitrogen atoms in 1, 2 and 7 show considerable deviation from the expected trigonal-planar geometry. The observed dihedral angles and the orientation
    通式的有机膦二酰胺[R 1 P(O)(NHR 2)2 ](1 - 8 ; R 1 =博士中,Cy或吨卜和R 2 = CY,我PR,吨卜或迪普)已经制备由添加P,P “ -二氯(烷基/芳基)膦氧化物,R 1 P(O)Cl 2,到伯胺 在 甲苯。通过缓慢的方法可以高产率地合成PhP(O)(NH t Bu)2 (1)氧化作用数天之内在空气中收集PhP(NH t Bu)2。所有新化合物的特征均在于元素分析 并通过 红外,EI质量和NMR(1 H和31 P)光谱学。的[PHP(O)(NH分子结构吨丁基)2 ](1),[PhPO(NHDipp)2 ](2)和[吨BUP(O)(NH我PR)2 ](7)已经被确定通过单晶X射线衍射研究。酰胺基氮原子图1,图2和图7中的曲线显示与预期的三角平面几何形状有相当大的偏差。观察到的二面角和氮这些化合物中的孤对(lp)指向lp多重键合中lp(N)→ σ*(P–X)型
  • A heterometallic (Fe<sub>6</sub>Na<sub>8</sub>) cage-like silsesquioxane: synthesis, structure, spin glass behavior and high catalytic activity
    作者:Alexey N. Bilyachenko、Mikhail M. Levitsky、Alexey I. Yalymov、Alexander A. Korlyukov、Anna V. Vologzhanina、Yuriy N. Kozlov、Lidia S. Shul'pina、Dmytro S. Nesterov、Armando J. L. Pombeiro、Frédéric Lamaty、Xavier Bantreil、Amandine Fetre、Diyang Liu、Jean Martinez、Jérôme Long、Joulia Larionova、Yannick Guari、Alexander L. Trigub、Yan V. Zubavichus、Igor E. Golub、Oleg A. Filippov、Elena S. Shubina、Georgiy B. Shul'pin
    DOI:10.1039/c6ra07081g
    日期:——
    The exotic "Asian Lantern" heterometallic cage silsesquioxane [(PhSiO1.5)20(FeO1.5)6(NaO0.5)8(n-BuOH)9.6(C7H8)] (I) was obtained and characterized by X-ray diffraction, EXAFS, topological analyses and DFT calculation. The magnetic properties investigations revealed that it shows...
    获得了奇异的“亚洲灯笼”杂金属笼型倍半硅氧烷[(PhSiO1.5)20(FeO1.5)6(NaO0.5)8(n-BuOH)9.6(C7H8)](I)并通过X射线衍射进行了表征,EXAFS,拓扑分析和DFT计算。磁性研究表明,它表明...
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰